Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 356

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 356
---
 Rewell’s customer relationship management, handled via our customer service team and in -appcommunication through the Rewell platform, fosters customer loyalty and retention. Customers can access additional Rewell solutions such as the “Continuous Evolution Kit” microbiome kit and individual telemedicine session through the platform. Rewell’s customer experience team collects user feedback and market insights to guide continuous improvement to the platform to satisfy customers’ needs and maintain an experience that promotes word -of -mouth. Rewell also provides nutritionists certified or not in nutrigenetics, to become affiliates to expand their service offerings. Additionally, external nutritionists have the option to certify themselves in nutrigenetics through the Rewell team, allowing them to deliver enhanced health management services and generate additional revenue through the Rewell platform. 183 Currently, Rewell is exclusively available in Argentina. However, as a preparation to expand Rewell, we are currently obtaining microbiome samples from international markets to build a proprietary data base and offer Rewell in additional countries. Heritas Diagnostics Commercial Operations Heritas Diagnostics’ commercial operations are designed to deliver precise diagnostic information through clinical genetic tests, along with a range of treatment alternatives via detailed reports, aimed at enhancing patient care. This service is commercialized through clinical laboratories, which offer these tests to patients and healthcare providers. These laboratories are onboarded and receive continuous commercial and technical assessment to offer the genetic tests to their customer base. Clinical laboratories collect samples, ship them to our Argentine Wet -Labfor processing, and once results are complete, these are sent to the clinical laboratory to be sent to their customer. Once samples are processed, the Company generates reports with the results, which CIBIC then delivers to patients and physicians. For the services provided, the Company sets a price for each category of tests, which CIBIC pays per test requested to Heritas Argentina. CIBIC then sells these tests to end consumers at a price it determines. Revenue generated from selling the tests and other genetics sequencing services is recognized at a point in time when the reports with the results of the tests are sent to CIBIC. Heritas Diagnostics conducts its marketing and sales through key partners, including CIBIC and Meyer. For more information, please refer to “ OmnigenicsAI Management’s Discussion and Analysis of Financial Condition and Results of Operations — Basis of Preparation and Significant Accounting Policies — Revenue recognition.” In respect of Heritas Diagnostics, marketing and sales is conducted by distribution partners. We support these by employing targeted marketing strategies to healthcare institutions, clinics